In today's increasingly strict quality management of the entire life cycle of drugs, the compliance of pharmaceutical excipients has become a key prerequisite for the successful registration of formulations. Recently,Nanjing Chemical Reagent Co., LtdAnnounce itPotassium sulfate pharmaceutical excipientIt has been registered and officially announced at the National Center for Drug Evaluation (CDE) with registration number F20250000661. This marks that the product has complete regulatory qualifications and can be directly used for drug registration and application, providing efficient and reliable excipient solutions for pharmaceutical companies.

Potassium sulfate pharmaceutical excipientWidely used in electrolyte supplements, sustained-release formulations, and injections to regulate potassium ion concentration or as an excipient. The Nanjing reagent adopts recrystallization process and multi-step purification technology, and key impurities (such as heavy metals, chlorides, moisture, etc.) are strictly controlled below the limits of the Chinese Pharmacopoeia to ensure the safety of the formulation; Secondly, relying on intelligent production workshops and a full traceability system, the entire process of quality monitoring from raw material procurement to finished product delivery is achieved, with minimal differences between batches, meeting the strict requirements for auxiliary material stability in large-scale production; Suitable for various solid and semi-solid formulations such as tablets, granules, oral solutions, etc., it can be used as an osmotic pressure regulator, filler, or pH buffer, providing flexible formulation support for formulation research and development.

As a deep cultivator in the field of medicinal excipients,Nanjing reagentAlways with the mission of "serving the pharmaceutical industry and safeguarding drug safety", we have launched multiple medicinal excipient products registered through CDE, covering multiple categories such as inorganic salts, organic excipients, coating materials, etc. this timePotassium sulfate pharmaceutical excipientThe approval is another important achievement of the company under the strategy of "compliance, specialization, and internationalization". In the future, Nanjing Reagent will continue to increase research and development investment, focus on the pharmaceutical industry's demand for excipients, provide integrated solutions from product supply to technical support, and work together with upstream and downstream partners to promote China's pharmaceutical industry towards higher quality and higher standards.